Progress in Melanoma
Oncologist Michael Postow discusses how targeted therapies and drugs that boost the immune system are changing the outlook for patients.
Immunotherapy and targeted therapies have dramatically improved outcomes for some melanoma patients. Oncologist Michael Postow from Memorial Sloan Kettering Cancer Center in New York City discusses what to ask your doctor about these new treatments. To learn more about research on combination immunotherapies, read “Making a Match,” which appeared in the Winter 2016/2017 issue of Cancer Today. | Video produced by Patient Power LLC.